đ¶ââïžđ§ đȘ
In a recent study published in the journal Scientific Reports, researchers explored how changes in daily step counts and variability affect cognitive function in older adults during a 10-week physical activity intervention.
Study: Association between changes in habitual stepping activity and cognition in older adults. Image Credit: SibRapid / Shutterstock.
Background
Posted in neuroscience
(TBI) is a sudden injury that causes damage to the brain. It may happen when there is a blow, bump, or jolt to the head. This is a closed head injury. A TBI can also happen when an object penetrates the skull. This is a penetrating injury.
Symptoms of a TBI can be mild, moderate, or severe. Concussions are a type of mild TBI. The effects of a concussion can sometimes be serious, but most people completely recover in time. More severe TBI can lead to serious physical and psychological symptoms, coma, and even death.
For many of these individuals, the response to repotrectinib lasted for several years.
âRepotrectinib can lead to long-term responses for patients with ROS1 fusionâpositive lung cancers, including those who have and have not received prior targeted therapy,â said Alexander Drilon, M.D., of Memorial Sloan Kettering Cancer Center, who led the TRIDENT-1 study.
Treatment with repotrectinib also shrank tumors that had spread to the brain, a common location for lung metastases, the researchers reported.
Register for free to get subscriber-only benefits: https://closertotruth.com/If consciousness is 100% physical, we would have to conclude that the same kindâŠ
Synchron on Monday plans to launch an onlineâŠ
WASHINGTON, April 8 (Reuters) â Synchron Inc, a rival to Elon Muskâs Neuralink brain implant startup, is preparing to recruit patients for a large-scale clinical trial required to seek commercial approval for its device, the companyâs chief executive told Reuters.
Synchron on Monday plans to launch an online registry for patients interested in joining the trial meant to include dozens of participants, and has received interest from about 120 clinical trial centers to help run the study, CEO Thomas Oxley said in an interview.
âPart of this registry is to start to enable local physicians to speak to patients with motor impairment,â he said. âThereâs a lot of interest so we donât want it to come in a big bottleneck right before the study weâll be doing.â
Recent research in mice investigates a new, immunotherapy-based approach to treating Alzheimerâs disease aiming to clear toxic protein accumulations in the brain.
From Caltech & NVIDIA
This explains the prospect of #deeplearning on advancing science, #simulation, and design.
âItâs not much you can do about it. Other than fight it and if you fight and you quit, then you are not gonna make it,â he said.
The founders of this Malibu-based class say it challenges the mind and body to work together, getting stronger in the process.
John Wakefield, the creator and co-founder of drumboxing in California, told KCBS, âThe connection with rhythm, tying it in with motor skills, really training the brain like you train the body putting it in a situation where it has to react.â
Certain RNA molecules in the nerve cells in the brain last a life time without being renewed. Neuroscientists from Friedrich-Alexander-UniversitĂ€t Erlangen-NĂŒrnberg (FAU) have now demonstrated that this is the case together with researchers from Germany, Austria and the U.S.
A medication used to treat diabetes appeared to halt the progression of Parkinsonâs symptoms in a phase 2 trial of people in the early stages of the disease. While more research is needed to see how large the effect is and how long it might last, the news is encouraging in the hunt for new Parkinsonâs treatments.
The challenge: More than 8.5 million people worldwide are living with Parkinsonâs, a progressive neurodegenerative disease caused by the loss of brain cells that produce dopamine, which helps neurons communicate.
Common Parkinsonâs symptoms include tremors, stiffness, and impaired cognition. Meds that replace dopamine can help alleviate those, but they donât address the underlying cause â the loss of dopamine neurons â and so the disease progresses.
